SQZ Biotechnologies financials at a glance

+ Portfolio

The revenue of SQZ Biotechnologies is reported as 0.02148 billion Dollars in the fiscal year 2022. The earnings were -25.89 Dollars per share in 2022, which was 3.98 lower than 2021. And about -0.08407 billion Dollars are reported as free cash flow in the financials of SQZ Biotechnologies 2022. No dividends were paid to the shareholders of the SQZ Biotechnologies stock OTCPK:SQZB in the financial year 2022.

$21.48M

Revenue

$-25.89

Earnings Per Share

-,230.50%

Gross Margin %

$-84.07M

Free Cash Flow

Revenue

21.48

Earnings Per Share

-25.89

Gross Margin %

-,230.50

Free Cash Flow

-84.07

Financials

Year	Year	TTM	2022	2021	2020	2019
Rev.	Revenue	N/A	$21.48M	$27.10M	$21.00M	$20.11M
GM %	Gross Margin %	0.00%	-,230.50%	-,158.87%	-,145.48%	0.00%
OM	Operating Margin	0.00%	0.00%	-,253.78%	-,243.16%	0.00%
EPS	Earnings Per Share	$-2.43	$-25.89	$-24.90	$-93.50	$-23.50
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	-0.00%	-0.00%	0
Sha.	Shares	N/AM	29.49M	28.15M	27.87M	1.67M
OCF	Operating Cash Flow	N/A	$-83.55M	$0.00M	$-43.15M	$0.00M
FCF	Free Cash Flow	N/A	$-84.07M	$0.00M	$-44.33M	$0.00M
FCFS	Free Cash Flow Per Share	$-2.53	$-2.92	$-3.00	$-8.21	$0.00

SQZ Biotechnologies financials at a glance

Financials

Discover